ROR1 and ovarian cancer: In addition, we also sought to determine the therapeutic potential of targeting these receptors by performing an extensive suite of in vitro experiments, exploring the functional role of ROR2, its sister receptor, ROR1 and putative ligand, Wnt5a in ovarian cancer.